UBC researchers are studying how pregnant women who have been vaccinated can pass on antibodies to their baby.
The 2009 H1N1 outbreak may have played a role in ushering in this development in maternal and infant care. Because the pandemic spread quickly both Health Canada and the US Centers for Disease Control advised at-risk populations, including expectant mothers, to be vaccinated. An estimated 41% of Canadians followed the advice (including as estimated 47% of pregnant women).
The heightened awareness created by the H1N1 outbreak and the subsequent availability of new data, specifically from pregnant women and infants, are setting the stage for vaccination during pregnancy as a bona fide public health strategy. The newly available data, combined with decades of safety records from widely used vaccines and a positive shift in perception toward vaccinating pregnant women, have made it possible to attempt a large-scale clinical trial.
Dr Deborah Money, professor in UBC’s Department of Obstetrics and Gynaecology, is leading the Vancouver portion of a national study using the pertussis vaccine. The research team is recruiting participants from across Canada to receive the vaccine during their 34th week of pregnancy and have their blood and breast milk collected and analyzed, along with the baby’s cord blood at the time of delivery.
If the results turn out to be what the team expects, a long list of infectious diseases, including influenza, pneumococcus, and meningitis, and potentially group B streptococcus, cytomegalovirus, and respiratory syncytial virus, could be a thing of the past.
To refer patients to the study, contact Lilija Berngards, Research Nurse at the Women’s Health Research Institute, by telephone at 604 875-2424 or visit www.whri.org for more information.
Above is the information needed to cite this article in your paper or presentation. The International Committee
of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally
accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
About the ICMJE and citation styles
The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.
An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.
BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:
- Only the first three authors are listed, followed by "et al."
- There is no period after the journal name.
- Page numbers are not abbreviated.
For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org